Contact us
Mobile menu not yet fully implemented
Find out what's happening in the area of Horizon Europe, Digital Europe and Horizon 2020
Starts in 2 months from now
LocationRoyal Military Academy
ProgrammesSubject to approval by the Council of Ministers, BELSPO and the RHID will launch the 5th call in the frame of the Defence-related Research Action DEFRA.
To inform potential applicants about the context, scope and modalities of this call and to offer them network opportunities, an information day will be held on Wednesday 22 January 2025 (08h30 – 16h30) at the Royal Military Academy.
More information on the programme and registration modalities will become available at the beginning of December 2024 on the DEFRA website.
We offer news and event updates, covering all domains and topics of Horizon Europe, Digital Europe & EDF (and occasionally, for ongoing projects, Horizon 2020).
Stay informed about what matters to you.
By signing up, you can opt in for e-mail notifications and get access to
a personalised dashboard that groups all news updates and event announcements in your domain(s).
Only for stakeholders located in Flanders
Health Culture and society Digital, Industry & Space Climate, Energy, Mobility Defence
Security Digital, Industry & Space AI, data & cloud Cybersecurity Defence
Security Cybersecurity Defence EDF NATO-EDA
The METHYLOMIC project, ‘targeting hope for personalised medicine in immune-mediated inflammatory diseases’ obtained funding from Horizon Europe’s Health Cluster. The project aims to personalise treatment allocation and enhance the effectiveness of medications for chronic immune-mediated diseases such as Crohn’s disease, rheumatoid arthritis, and psoriasis. BIRD, the Belgian inflammatory bowel disease research and development group, is a partner in the project and is involved in the OmiCrohn trial, a prospective randomised clinical trial for individualised therapy in Crohn’s disease patients. With BIRD’s active role in this trial, the project is set to deliver predictive, biomarker-based therapies that bring renewed hope for Crohn’s disease patients across Europe.
